| Sign In to gain access to subscriptions and/or personal tools. |
DOI: 10.1177/000992287701600409 Hexachlorophene in the Newborn NurseryA Risk-Benefit Analysis and ReviewDepartment of Pharmacology, Professor of Internal Medicine, Chief, Clinical Pharmacology
Departments of Pharmacology, and Pediatrics
Department of Pediatrics A critical review of the available data on the risks and benefits of hexa chlorophene suggests that there is ample evidence for the toxic potential; whereas there is no substantial evidence of its benefit in life-threatening staph 80/81 epidemics, and effective less toxic alternatives are available. In view of its limited usefulness and definite toxicity, the routine use of hexachlorophene is unjustified.
|